Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Systemic lupus erythematosus
What strategies have you found most effective in improving long-term medication adherence in patients with SLE?
Related Questions
How would you manage a patient SLE who is planning pregnancy and has serologically active disease (elevated dsDNA, low C3/C4), mild arthritis, and is otherwise asymptomatic on hydroxychloroquine 200 mg BID and methotrexate 15 mg weekly?
Do you favor obinutuzumab over voclosporin for patients with lupus nephritis and significant proteinuria and a history of non-adherence to medications?
What factors do you weigh most heavily when choosing between belimumab and voclosporin as part of a triple therapy regimen for newly diagnosed class IV LN?
Would you consider combination belimumab and anakinra for a patient who has SLE and MAS?
Would you always pursue excisional biopsy versus core biopsy to confirm Kikuchi's disease?
Would you be comfortable combining rituximab with voclosporin in patients with lupus nephritis not responding to standard therapy?
Do you check for JCV before starting belimumab?
What approach do you use for monitoring renal response to LN therapy?
Are you comfortable using belimumab in patients with a history of significant depression?
In patients without Raynaud’s, how frequently do you perform nailfold examination during the initial clinical assessment?
